U.S. Agents - Responsibility for reporting adverse events to the FDA

QAMed26

Starting to get Involved
#1
Good morning fellow Cove-ers

We are a Canadian medical device company who currently uses a U.S Agent as required for any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States.

Upon review of our contract with our agent, it says “Please note that the U.S. Agent has no responsibility related to reporting of adverse events under the Medical Device Reporting regulation (21 CFR Part 803) or submitting510(k) Premarket Notifications (21 CFR Part 807, Subpart E”
This is in line with what is stated on the FDA website U.S. Agents

However, 21 CFR 803.50 states:
Every foreign manufacturer whose devices are distributed in the United States shall designate a U.S. agent to be responsible for reporting in accordance with §807.40 of this chapter. The U.S. designated agent accepts responsibility for the duties that such designation entails. Upon the effective date of this regulation, foreign manufacturers shall inform FDA, by letter, of the name and address of the U.S. agent designated under this section and §807.40 of this chapter, and shall update this information as necessary. Such updated information shall be submitted to FDA, within 5 days of a change in the designated agent information.
(b) U.S.-designated agents of foreign manufacturers are required to:
(1) Report to FDA in accordance with §803.50, 803.52, 803.53, and 803.56;
(2) Conduct, or obtain from the foreign manufacturer the necessary information regarding, the investigation and evaluation of the event to comport with the requirements of §803.50;
(3) Forward MDR complaints to the foreign manufacturer and maintain documentation of this requirement;
(4) Maintain complaint files in accordance with §803.18; and
(5) Register, list, and submit premarket notifications in accordance with part 807 of this chapter.

As it is noted that we can only have one U.S agent, how do we go about resolving this apparent contradiction between the U.S. Agent’s responsibilities and 21 CFR 803.50?

My U.S. Agent hasn't responded to my enquiries (which is another issue altogether) so I was hoping someone here could point me in the right direction.

Thanks!!
 
Elsmar Forum Sponsor

Sidney Vianna

Post Responsibly
Staff member
Admin
#2
how do we go about resolving this apparent contradiction between the U.S. Agent’s responsibilities and 21 CFR 803.50?
It seems to me that your designated US Agent is risk-adverse and attempting to refuse any responsibility for something that, according to your post, they have to be responsible for. So, the dilemma is that the contract contravenes a regulatory requirement and it creates problems for your organization.

As I see it, the only plausible solution is for the agent to accept the regulatory mandate for the reporting responsibility, or, you find another agent who does.

Good luck.
 

QAMed26

Starting to get Involved
#3
I would agree, however the text in their contract is taken word for word from the FDA website on Responsibilities of a U.S. agent.

The U.S. agent must either reside in the U.S. or maintain a place of business in the U.S. The U.S. agent cannot use a post office box as an address. The U.S. agent cannot use just an answering service. They must be available to answer the phone or have an employee available to answer the phone during normal business hours.
The responsibilities of the U.S. agent are limited and include:

- assisting FDA in communications with the foreign establishment,
- responding to questions concerning the foreign establishment's devices that are imported or offered for import into the United States,
- assisting FDA in scheduling inspections of the foreign establishment and
if FDA is unable to contact the foreign establishment directly or expeditiously, FDA may provide information or documents to the U.S. agent, and such an action shall be considered to be equivalent to providing the same information or documents to the foreign establishment.

Please note that the U.S. agent has no responsibility related to reporting of adverse events under the Medical Device Reporting regulation (21 CFR Part 803), or submitting 510(k) Premarket Notifications (21 CFR Part 807, Subpart E).

Can the FDA contradict itself?
 

Sidney Vianna

Post Responsibly
Staff member
Admin
#4
Can the FDA contradict itself?
I agree with you that it looks like a contradiction and, possibly the best way forward is to ask the FDA themselves.

They list the following communication channels to seek clarifications on this issue:

For Questions about Medical Device Reporting, including interpretation of MDR policy:

Call: (301) 796-6670
Email: [email protected]
 

QAMed26

Starting to get Involved
#5
Re: U.S. Agents - Responsibility for reporting adverse events

:thanx::thanx::thanx:

There are so many different email addresses for the FDA that it is sometimes hard to figure out who to email.

I will do that immediately.

Thanks again!
 

Mark Meer

Trusted Information Resource
#6
Re: U.S. Agents - Responsibility for reporting adverse events

Thanks QAMed26 for this timely thread. I was just wondering the exact same thing!

My assumption is that, despite 21 CFR 803.50, in practice the US agent is rarely, if ever, contacted. Users would have to look up the US Agent for the company online (without any instruction to do so), as opposed to simply contacting the manufacturer/distributor directly via the contacts required in the labelling as per 21 CFR 801.1.

Hence, the contradiction you've identified is likely almost always a non-issue. In practice, the US Agent is probably nothing more than the occasional go-between between the FDA and the organisation. I note that 21 CFR 803.50 also requires US Agents to maintain complaint files, and submit pre-market notifications. Does this ever happen as required in practice these days?! I'm assuming this is some legacy regulation from times past, that has not been updated because, like I say, it's likely, for the most part, a non-issue in practice.

That's just my assumption, however, and does not excuse the contradiction.

Please post back on this thread when you hear back from the FDA...
I (and probably many others that have the same question) would very much appreciate hearing the FDA's explanation!

MM.
 

Ronen E

Problem Solver
Staff member
Moderator
#7
Re: U.S. Agents - Responsibility for reporting adverse events

By face value it does look like a contradiction.

I have no doubt that in a case of contradiction between the regulation and website (any website) contents, the rgeulation prevails, no matter how old and seemingly archaic.

Please note that the regulation quoted on the FDA website (the actual verbatim regulation text) in not guaranteed to be the latest; you should always check at eCFR.
 

Ajit Basrur

Staff member
Admin
#8
Interesting question. Agree there looks like a contradiction.

QAMed26, please let us know when you hear more on this subject. Thank you!
 

QAMed26

Starting to get Involved
#9
So interestingly enough, I heard back from the FDA twice yesterday (I really had no expectation that I would hear back from them at all).

Their first response was essentially saying they would look into it and then the final response near the end of the day was that the clause I was citing was actually 803.58 not 803.50, and 803.58 was indefinitely stayed in 2014 so there is no contradiction.

So at least I could sleep better last night.

Thanks to all who responded and for pointing me to the right FDA department. I really do enjoy this forum.
 

Ronen E

Problem Solver
Staff member
Moderator
#10
This is the bit that was missing in the quote:

Effective Date Note:

At 79 FR 8846, Feb. 14, 2014, part 803 was revised. At 79 FR 8855, Feb. 14, 2014, 803.58 was stayed indefinitely.
It appears both on eCFR and on the FDA website (21 CFR 803).

Does anybody know which court stayed it, and why?
 
Thread starter Similar threads Forum Replies Date
Marc User Agents of Forum Visitors - 6 November 2018 Forum News and General Information 0
Sidney Vianna IAF Mandatory Document #23 - Control of CB Franchisees and Agents Registrars and Notified Bodies 3
R Damage when Border Agents open Shipments Supplier Quality Assurance and other Supplier Issues 8
W Cleanroom Cleaning Agents for cleaning a Class 7 Cleanroom Other Medical Device and Orthopedic Related Topics 9
F How to manage Intermediary Sales Agents ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
J Process Agents List - Auxiliary items? ISO 13485:2016 - Medical Device Quality Management Systems 3
I Do company sales agents/distributors need to go through supplier evaluation process? Other Medical Device and Orthopedic Related Topics 5
M FDA or USDA Approved Cleaners - Cleaning Agents like Detergents Food Safety - ISO 22000, HACCP (21 CFR 120) 11
Wes Bucey Agencies and Agents - good guys or bad guys? Career and Occupation Discussions 9
Paul Simpson Agents operating for a certification body / registrar Registrars and Notified Bodies 14
V UDI - OEM or OBL / Legal Manufacturer Responsibility CE Marking (Conformité Européene) / CB Scheme 0
T ISO 13485 - 5.5.1 Responsibility and authority - Small Company Independence ISO 13485:2016 - Medical Device Quality Management Systems 13
B Product Safety Responsibility - Job shop such as a machine shop AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 10
D DHF Responsibility after design handover Document Control Systems, Procedures, Forms and Templates 4
L Global distributor vigilance responsibility Medical Device and FDA Regulations and Standards News 14
S Responsibility of intercessor services provider about services's quality ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
B Main responsibility for Control Plans - creating and maintaining FMEA and Control Plans 13
M EU MDR - UDI requirements and responsibility guidance EU Medical Device Regulations 1
Mr Skeleton PV (Production Validation) test plan responsibility APQP and PPAP 21
Shawn Mosby DFMEA when the supplier doesn't have design responsibility APQP and PPAP 14
W Organizational Responsibility for Environmental Compliance of Products REACH and RoHS Conversations 4
T Design responsibility for customized product per customer requirements Design and Development of Products and Processes 4
T Decontamination responsibility on customer complaint investigation Customer Complaints 4
lyobovnik Matters being audited, independence, participation and direct responsibility 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
P Responsibility for Design Transfer - OEM vs. CM ISO 13485:2016 - Medical Device Quality Management Systems 6
M Where does our regulatory responsibility end? ISO 13485:2016 - Medical Device Quality Management Systems 11
S Contract Packager or Repackager? And can client assume responsibility? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
Fender1 Customer specified Item Defect Corrective Action Responsibility Customer Complaints 18
G FAI (First Article Inspection) Responsibility - QC or Engineering? ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 3
E Manufacturer's responsibility to notify the NB regarding Medical Device End-of-Life CE Marking (Conformité Européene) / CB Scheme 1
sutie What is Ethics Escalation (“Whistle-Blowing”) Policy - Corporate Responsibility IATF 16949 - Automotive Quality Systems Standard 7
A Leadership Responsibility in an ISO 9001:2015 Quality Management System ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 2
W Shared Responsibility Between Spec Provider and Contract Manufacturer 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
L What is the difference between Objectives and Responsibility ? ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 4
L Responsibility for Labeling in Multi-Location Group Document Control Systems, Procedures, Forms and Templates 5
JoCam ATEX - Responsibility for a Declaration of Conformity Various Other Specifications, Standards, and related Requirements 7
E Manufacturer Responsibility (vs. User/Customer) for Preventive Maintenance/Repair 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
S Specification Verification Responsibility AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 3
V VAG Customer Specific Requirements - Product Safety Responsibility Customer and Company Specific Requirements 1
G Application of RASI (Responsibility, Authority, Support, Information) Chart IATF 16949 - Automotive Quality Systems Standard 5
K Hardware and OS Responsibility in FDA 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
Kronos147 Customer Request for Corrective Action - Responsibility AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 2
S Whose responsibility is it to issue Corrective Action Requests? Internal Auditing 8
D Requirements & Responsibility regarding Fire Foam in an Office Miscellaneous Environmental Standards and EMS Related Discussions 5
O Vendor (Supplier) Responsibility - Re: Quality Audits 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 5
M Does "Responsibility" need to be mentioned in the Corrective Actions ? AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 22
M What is our level of responsibility in the IQ, OQ, PQ processes? ISO 13485:2016 - Medical Device Quality Management Systems 1
Q How to meet Responsibility and Authority (Clause 5.5.1) Requirements ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 11
E Aging/Shelf-Life Testing Responsibility 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
H Definition Executive Responsibility - Legal Definition Definitions, Acronyms, Abbreviations and Interpretations Listed Alphabetically 11

Similar threads

Top Bottom